What We're Reading: Page 321
Industry reads hand-picked by our editors
Feb 10, 2017
-
The Guardian
Cancer drug prices must come down, say leading research institutes
-
Forbes
Mysterious $5 billion biotech Moderna hit with legal setback related to key technology
-
TheStreet
CVS remains unsure about the future of Obamacare, CEO says
-
The New York Times
Doctors see gains against ‘an urgent threat,’ C. diff
Feb 09, 2017
Feb 08, 2017
-
NPR
White House says Medicare should leverage its buying power to pull down drug prices
-
Bloomberg
The pharma job from hell: Low salary to fix sinking giant Teva
-
Reuters
Merrimack Pharma employee arrested on U.S. insider trading charge
-
BuzzFeed
A lobbying group is freaking out over what Trump may do to drug prices
Feb 07, 2017
Feb 06, 2017
Feb 03, 2017
-
Bloomberg
Trump volatility index takes pharma companies on a wild ride
-
Xconomy
Drug-hunting startup from Scripps attracts Celgene alum, $50M backing
-
TheStreet
Side effect kills cancer patient in Stemline Therapeutics drug trial; company raises money
-
The Huffington Post
New rules aim To keep patients on medications that work
Previous
